Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multiple-Site, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study to Assess the Safety and Tolerability of Inhaled SNSP113 in Healthy Male Subjects (Part A) and Subjects With Stable Cystic Fibrosis (Part B)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03309358
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:54.803448+00:00
Published At
2018-05-25T00:00:00+00:00
Record Updated At
2018-05-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Diseases", "Pulmonary Disease", "Cystic Fibrosis", "Cystic Fibrosis Lung", "Cystic Fibrosis Pulmonary Exacerbation", "Cystic Fibrosis With Exacerbation", "Respiratory Tract Disease", "Pulmonary Inflammation", "Multi-antibiotic Resistance", "Antibiotic Resistant Infection", "Lung Infection", "Lung Infection Pseudomonal", "Lung; Infection, Atypical Mycobacterium", "Burkholderia Infections", "Burkholderia Cepacia Infection", "Lung Inflammation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-05-25"
protocolSection.identificationModule.nctId
"NCT03309358"
protocolSection.identificationModule.officialTitle
"A Multiple-Site, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) Study to Assess the Safety and Tolerability of Inhaled SNSP113 in Healthy Male Subjects (Part A) and Subjects With Stable Cystic Fibrosis (Part B)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lung Diseases (protocolSection.conditionsModule.conditions)
  • Pulmonary Disease (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis Lung (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis Pulmonary Exacerbation (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis With Exacerbation (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Disease (protocolSection.conditionsModule.conditions)
  • Pulmonary Inflammation (protocolSection.conditionsModule.conditions)
  • Multi-antibiotic Resistance (protocolSection.conditionsModule.conditions)
  • Antibiotic Resistant Infection (protocolSection.conditionsModule.conditions)
  • Lung Infection (protocolSection.conditionsModule.conditions)
  • Lung Infection Pseudomonal (protocolSection.conditionsModule.conditions)
  • Lung; Infection, Atypical Mycobacterium (protocolSection.conditionsModule.conditions)
  • Burkholderia Infections (protocolSection.conditionsModule.conditions)
  • Burkholderia Cepacia Infection (protocolSection.conditionsModule.conditions)
  • Lung Inflammation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.